Literature DB >> 4617707

Sensitization to tumour-associated antigens in human breast carcinoma.

A J Cochran, R M Grant, W G Spilg, R M Mackie, C E Ross, D E Hoyle, J M Russell.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4617707     DOI: 10.1002/ijc.2910140103

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  8 in total

1.  Immunological tests in carcinoma of the prostate.

Authors:  C M Evans; J G Bowen
Journal:  Proc R Soc Med       Date:  1977-06

2.  Formalinized tumour cells in the leucocyte migration inhibition test.

Authors:  C E Ross; A J Cochran; D E Hoyle; R M Grant; R M Mackie
Journal:  Clin Exp Immunol       Date:  1975-10       Impact factor: 4.330

Review 3.  Therapeutic vaccination with tumor cells that engage CD137.

Authors:  Karl Erik Hellstrom; Ingegerd Hellstrom
Journal:  J Mol Med (Berl)       Date:  2003-02-08       Impact factor: 4.599

4.  Cellular hypersensitivity to autologous tumor extract in patients with breast carcinoma.

Authors:  T Akiyoshi; Y Nakamura; M Kawaguchi; H Tsuji
Journal:  Jpn J Surg       Date:  1978-09

5.  Human malignant melanoma antigenic properties of phenol water extracts.

Authors:  L Suter; H Tilkorn; P M Kövary
Journal:  Arch Dermatol Res       Date:  1979-02-23       Impact factor: 3.017

6.  A serologic study of cultured breast cancer cell lines: lack of antibody response to tumour specific membrane antigens in patients.

Authors:  M Higuchi; D S Robinson; R Cailleau; R F Irie; D L Morton
Journal:  Clin Exp Immunol       Date:  1980-01       Impact factor: 4.330

7.  Horizontal studies of cell mediated immune reactions to autologous tumour antigens in patients with operable mammary carcinoma.

Authors:  B M Jones; A R Turnbull
Journal:  Br J Cancer       Date:  1975-09       Impact factor: 7.640

8.  Demonstration of cellular immunity in chronic myeloid leukaemia using leucocyte migration inhibition assay.

Authors:  S G Gangal; B P Gothoskar; C S Joshi; S H Advani
Journal:  Br J Cancer       Date:  1976-03       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.